ReviewToxins2026
Metal-Organic Framework-Immobilized Mycotoxin-Degrading Enzymes: Interfaces, Host Design, and Food/Feed Applications.
Review in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Mycotoxin contamination remains a persistent threat to food and feed safety owing to the chemical stability of many mycotoxins, frequent co-occurrence, and matrix-dependent risks. Enzymatic detoxification enables structure-targeted transformation of toxicity-determining motifs, such as epoxide rings, reactive double bonds, amide linkages, and lactone structures. However, free mycotoxin-degrading enzymes are often constrained by poor operational stability, difficult recovery, and limited adaptability to complex matrices. Metal-organic frameworks (MOFs) provide programmable microenvironments for enzyme immobilization through tunable pore structures, interfacial chemistry, and confinement effects. This review links toxic structural motifs with enzymatic transformation targets, discusses MOF-enzyme interface engineering and representative host-enzyme compatibility, and evaluates application modes including single-enzyme systems, multi-enzyme co-immobilization or cascade systems, adsorption-degradation coupling, and detection-degradation integration. Key bottlenecks involving enzyme leakage, mass-transfer limitation, real-matrix stability, scalable preparation, and biosafety are critically discussed. Rather than treating MOFs as passive enzyme carriers, this review proposes an application-oriented framework that integrates toxin structure, enzyme function, MOF interface regulation, matrix compatibility, and safety validation to guide the development of MOF-immobilized degrading enzymes for practical mycotoxin detoxification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.